Press releaseGlobe Newswire
OrthoPediatrics
KIDS · NASDAQ
$23.50+$1.47 (+6.67%)TodayMarket closed ·
Prev close $22.03
Latest news
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
OrthoPediatrics Q1 2026 Earnings Call: Complete Transcript
- Press releaseGlobe Newswire
OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance
- News
Earnings Scheduled For April 30, 2026
- News
Beyond The Numbers: 5 Analysts Discuss OrthoPediatrics Stock
- Press releaseGlobe Newswire
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For February 26, 2026
- Press releaseGlobe Newswire
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
- News
Demystifying OrthoPediatrics: Insights From 9 Analyst Reviews
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
Earnings Scheduled For August 5, 2025
- Press releaseGlobe Newswire
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
- News
Demystifying OrthoPediatrics: Insights From 7 Analyst Reviews
- News
Analyst Expectations For OrthoPediatrics's Future
- News
Demystifying OrthoPediatrics: Insights From 4 Analyst Reviews
- Press releaseGlobe Newswire
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
- Press releaseGlobe Newswire
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
- Press releaseGlobe Newswire
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
- News
The Latest Analyst Ratings For OrthoPediatrics
- News
The Latest Analyst Ratings For OrthoPediatrics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.